93 related articles for article (PubMed ID: 12839962)
1. Human Spy1 promotes survival of mammalian cells following DNA damage.
Barnes EA; Porter LA; Lenormand JL; Dellinger RW; Donoghue DJ
Cancer Res; 2003 Jul; 63(13):3701-7. PubMed ID: 12839962
[TBL] [Abstract][Full Text] [Related]
2. Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.
Porter LA; Dellinger RW; Tynan JA; Barnes EA; Kong M; Lenormand JL; Donoghue DJ
J Cell Biol; 2002 Apr; 157(3):357-66. PubMed ID: 11980914
[TBL] [Abstract][Full Text] [Related]
3. Speedy: a novel cell cycle regulator of the G2/M transition.
Lenormand JL; Dellinger RW; Knudsen KE; Subramani S; Donoghue DJ
EMBO J; 1999 Apr; 18(7):1869-77. PubMed ID: 10202150
[TBL] [Abstract][Full Text] [Related]
4. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities.
He G; Siddik ZH; Huang Z; Wang R; Koomen J; Kobayashi R; Khokhar AR; Kuang J
Oncogene; 2005 Apr; 24(18):2929-43. PubMed ID: 15735718
[TBL] [Abstract][Full Text] [Related]
5. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
Petersen BO; Lukas J; Sørensen CS; Bartek J; Helin K
EMBO J; 1999 Jan; 18(2):396-410. PubMed ID: 9889196
[TBL] [Abstract][Full Text] [Related]
7. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
Morris TA; DeLorenzo RJ; Tombes RM
Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
[TBL] [Abstract][Full Text] [Related]
8. Misregulated expression of the cyclin dependent kinase 2 protein in human fibroblasts is accompanied by the inability to maintain a G2 arrest following DNA damage.
Walker DH; Adami GR; Dold KM; Babiss LE
Cell Growth Differ; 1995 Sep; 6(9):1053-61. PubMed ID: 8519681
[TBL] [Abstract][Full Text] [Related]
9. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.
Yuan ZM; Huang Y; Whang Y; Sawyers C; Weichselbaum R; Kharbanda S; Kufe D
Nature; 1996 Jul; 382(6588):272-4. PubMed ID: 8717045
[TBL] [Abstract][Full Text] [Related]
10. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy.
Ohmori T; Yang JL; Price JO; Arteaga CL
Exp Cell Res; 1998 Dec; 245(2):350-9. PubMed ID: 9851876
[TBL] [Abstract][Full Text] [Related]
11. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
[TBL] [Abstract][Full Text] [Related]
12. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 inhibits cell proliferation through binding to PCNA and cdk2.
Fukami-Kobayashi J; Mitsui Y
Exp Cell Res; 1999 Feb; 246(2):338-47. PubMed ID: 9925749
[TBL] [Abstract][Full Text] [Related]
14. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
[TBL] [Abstract][Full Text] [Related]
15. The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosis.
McAndrew CW; Gastwirt RF; Donoghue DJ
Cell Cycle; 2009 Jan; 8(1):66-75. PubMed ID: 19106603
[TBL] [Abstract][Full Text] [Related]
16. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
Saville MK; Watson RJ
Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
[TBL] [Abstract][Full Text] [Related]
17. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
18. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.
Mann DJ; Child ES; Swanton C; Laman H; Jones N
EMBO J; 1999 Feb; 18(3):654-63. PubMed ID: 9927425
[TBL] [Abstract][Full Text] [Related]
19. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
20. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways.
Falck J; Petrini JH; Williams BR; Lukas J; Bartek J
Nat Genet; 2002 Mar; 30(3):290-4. PubMed ID: 11850621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
